Image-Guided SRT (GentleCure®)
May fit selected biopsy-proven basal cell carcinomas, squamous cell carcinomas, and SCC in situ. It avoids an incision but requires repeated visits and can cause short- and long-term skin changes.
Skin Cancer Center · Treatment choices
Yes—some selected basal and squamous cell skin cancers have non-surgical options. The biopsy diagnosis and tumor risk determine whether those choices are medically reasonable. Melanoma follows a surgical and staging pathway.
The short answer
Surgery remains preferred for many BCCs and SCCs because it removes the tumor and provides margin information. The right conversation begins with the pathology report, not a treatment name.
Selected pathways
These treatments are not interchangeable. Each has specific indications, limitations, and follow-up requirements.
May fit selected biopsy-proven basal cell carcinomas, squamous cell carcinomas, and SCC in situ. It avoids an incision but requires repeated visits and can cause short- and long-term skin changes.
May fit certain superficial BCCs or SCC in situ in carefully selected locations. Treatment takes weeks, often causes a significant local reaction, and is not appropriate for invasive or higher-risk disease.
An in-office destructive procedure for selected low-risk superficial cancers in appropriate locations. It leaves a healing wound and does not assess a complete surgical margin like excision or Mohs.
Most commonly used for precancers and only limited, carefully selected superficial cancers. These treatments are not substitutes for definitive care of invasive or high-risk skin cancer.
Side by side
Surgery / Mohs: Provides pathologic margin assessment; Mohs examines margins during the procedure.
Selected non-surgical care: Generally relies on treatment response and follow-up rather than complete surgical margin assessment.
Surgery / Mohs: Often completed in one procedure, with healing afterward.
Selected non-surgical care: May require days to weeks of topical therapy or repeated IG-SRT visits over several weeks.
Surgery / Mohs: Incision or reconstruction and a surgical scar that changes as healing matures.
Selected non-surgical care: No surgical incision for radiation or topicals, but inflammation and lasting pigment or texture changes can occur.
Surgery / Mohs: Many primary cancers and tumors where complete removal and margin control are especially important.
Selected non-surgical care: Carefully selected lower-risk or superficial cancers, or when surgery is less suitable or declined after informed discussion.
Why surgery may still lead
Excision and Mohs surgery physically remove the cancer and allow tissue to be examined. Mohs evaluates peripheral and deep margins during the procedure and can be especially useful for selected high-risk, recurrent, poorly defined, or anatomically sensitive tumors.
A surgical recommendation does not mean another option was ignored.
It may mean tumor biology, margin certainty, speed, or long-term treatment planning makes surgery the stronger choice.
Compare Mohs surgery and GentleCure®Common questions
Yes. Some selected basal and squamous cell skin cancers have non-surgical options. The correct choice depends on the biopsy diagnosis, subtype, depth, location, risk features, prior treatment, health, and ability to complete follow-up.
There is no single substitute for Mohs. Image-Guided SRT may be considered for selected BCC and SCC cases; topical treatment or destruction may fit some superficial low-risk cancers. High-risk tumors may still be best treated surgically.
Melanoma generally follows a surgical and staging pathway. GentleCure®, topical creams, freezing, and routine superficial radiation are not substitutes for appropriate melanoma surgery.
They avoid a surgical incision, but no treatment guarantees unchanged skin. Radiation, topical medicine, destruction, and freezing can produce pigment, texture, redness, crusting, or other lasting changes.
Surgery removes the tumor and allows pathologic assessment of margins. That can be especially important for high-risk, recurrent, aggressive, poorly defined, or deeply invasive tumors.
Begin with the pathology report and a dermatologist examination. Ask which options are medically reasonable for that exact lesion, how margins are assessed, what healing involves, and how follow-up will work.
Clinical sources
Every reasonable option, clearly explained
Juniper provides skin-cancer evaluation and treatment planning in Bend and Redmond. GentleCure® treatment, when appropriate, is delivered in Bend.